GSTM1 and deep vein thrombosis: In the present study, the timing of treatment initiation, duration of treatment,age, BMI, D-dimer level, and Hb level were not significantly associated with the efficacy of FPX7.5 for DVT, making it difficult to predict the efficacy of this drug.